Huadong Medicine

Huadong Medicine Pvt Ltd
SZSE: 000963
IndustryPharmaceuticals
Founded1993
HeadquartersHangzhou, China
Websitewww.eastchinapharm.com

HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since January 27, 2000. It has a listed share capital of 380,000,000 renminbi and a market capitalization of 126,323,040 renminbi as of July 2005. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.[1]

In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. [2]

References

  1. ^ China Listed Companies Handbook (Vol 4). Javvin Technologies. 2008. p. 69. ISBN 978-1-60267-023-5.
  2. ^ Newswires, M. T. (2025-06-11). "Huadong Medicine Gets Clinical Trial Approval for Roflumilast Foam | MarketScreener". www.marketscreener.com. Retrieved 2025-06-26.


This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.